Photodynamic therapy with E6 chlorin for chronic central serous chorioretinopathy

Authors

  • Taras Kustrin V.P. Filatov Institute of Eye Diseases and Tissue Therapy, National Academy of Medical Sciences of Ukraine
  • Ilia Nasinnik V.P. Filatov Institute of Eye Diseases and Tissue Therapy, National Academy of Medical Sciences of Ukraine
  • Oleg Zadorojnîi V.P. Filatov Institute of Eye Diseases and Tissue Therapy, National Academy of Medical Sciences of Ukraine
  • Andrii Korol V.P. Filatov Institute of Eye Diseases and Tissue Therapy, National Academy of Medical Sciences of Ukraine

Keywords:

photodynamic therapy, chlorin e6, central serous choriorathia

Abstract

Central serous chorioretinopathy is a chorioretinal disease characterized by the formation of a serous detachment of the neurosensory retina associated with decompensation of the retinal pigment epithelium. The aim of this study was to investigate the efficacy and safety of photodynamic therapy with Chlorin e6 in the treatment of patients with chronic central serous chorioretinopathy. Photodynamic therapy with Chlorin e6 is an effective and safe method for the treatment of patients with chronic central serous chorioretinopathy.

Downloads

Published

2026-04-25

Issue

No. 1(92) (2022): Supliment. Conferința științifico-practică a Oftalmologilor din municipiul Chișinău cu participare națională și internațională, ediția a VII-a „Actualități în oftalmologie”

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

How to Cite

[1]
Kustrin, T. et al. 2026. Photodynamic therapy with E6 chlorin for chronic central serous chorioretinopathy. Public Health Economy and Management in Medicine. 1(92) (Apr. 2026), 99–100.

Most read articles by the same author(s)

Similar Articles

1-10 of 82

You may also start an advanced similarity search for this article.